| Patents for C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132) |
|---|
| 08/03/2005 | CN1649831A Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient |
| 08/03/2005 | CN1213036C Novel amide derivatives |
| 08/02/2005 | US6924286 Sulfur compounds such as phenylmethyl [2R-hydroxy-3-[(3-methylbutyl) (phenylsulfonyl)amino]-1S-(phenylmethyl)propyl]carbamate, used for prevention of viral diseases and replication |
| 08/02/2005 | CA2170020C Retroviral protease inhibiting compounds |
| 07/28/2005 | WO2005067933A1 1-benzyl-5-piperazin-1-yl-3,4 dihydro-1h-quinazolin-2-one derivatives and the respective 1h-benzo(1,2,6)thiadiazine-2,2-dioxide and 1,4-dihydro-benzo(d) (1,3)oxazin-2-one derivatives as modulators of the 5-hydroxytryptamine receptor (5-ht) for the treatment of diseases of the central nervous system |
| 07/28/2005 | WO2005067502A2 Alkylamino, arylamino, and sulfonamido cyclopentyl amide modulators of chemokine receptor activity |
| 07/28/2005 | US20050165001 Quinazolinone and benzoxazinone derivatives and uses thereof |
| 07/28/2005 | US20050164883 agronomically tolerable salts, isomers and enantiomers of those compounds, are suitable for use as herbicides |
| 07/28/2005 | CA2552681A1 1-benzyl-5-piperazin-1-yl-3,4 dihydro-1h-quinazolin-2-one derivatives and the respective 1h-benzo(1,2,6)thiadiazine-2,2-dioxide and 1,4-dihydro-benzo(d) (1,3)oxazin-2-one derivatives as modulators of the 5-hydroxytryptamine receptor (5-ht) for the treatment of diseases of the central nervous system |
| 07/28/2005 | CA2551869A1 Alkylamino, arylamino, and sulfonamido cyclopentyl amide modulators of chemokine receptor activity |
| 07/27/2005 | EP1556052A2 Mitotic kinesin inhibitors |
| 07/27/2005 | CN1646525A Process for 5-[[2(R)-[1(R)-[3, 5-bis(trifluoromethyl)phenyl]ethoxy]-3(S)-(4-fluorophenyl)-4-morpholinyl]methyl]-1, 2-dihydro-3H-1, 2, 4-triazol-3-one |
| 07/27/2005 | CN1212166C Safety shield system for prefilled syringes |
| 07/26/2005 | US6921760 Psychotherapeutic agents. |
| 07/26/2005 | CA2253948C Carboline derivatives |
| 07/21/2005 | WO2005066144A1 Morpholine derivatives as norepinephrine reuptake inhibitors |
| 07/21/2005 | WO2005065779A1 Calcitonin gene related peptide receptor antagonists |
| 07/21/2005 | US20050159606 Fluorescent dye-fused lactone derivative covalently attaches to biological agent; xanthene or phenoxazine derivatives; chroman-2-one dyes; phosphoramidite linkages |
| 07/21/2005 | US20050159600 Crystalline R-guanidines, arginine or (L)-arginine (2S)-2-ethoxy-3-{4-[2-(10H-phenoxazin-10-yl)ethoxy]phenyl}propanoate |
| 07/21/2005 | US20050159448 Aryl aniline derivatives as beta2 adrenergic receptor agonists |
| 07/21/2005 | CA2549330A1 Calcitonin gene related peptide receptor antagonists |
| 07/20/2005 | CN1642973A A method for treating allergies |
| 07/20/2005 | CN1642928A Process for the preparation of morpholine derivatives and intermediates therefore |
| 07/20/2005 | CN1642554A Benzenesulphonate salt of a morpholine urea derivative for use as a CCR-3 antagonist in the treatment of inflammatory conditions |
| 07/20/2005 | CN1642553A N-{'(2S) -4- (3, 4-difluorobenzyl) morpholin-2yl!methyl} -2-{3-' (methylsulphonyl) amino! phenyl}acetamide as CCR3 antagonist for the treatment of inflammatory conditions |
| 07/20/2005 | CN1211367C Prostaglandin agonists and their use to treat bone disorders |
| 07/20/2005 | CN1211353C Unsaturated hydroximic acid derivatives as PARP inhibitors |
| 07/19/2005 | US6919482 A 1,4-bis(N-(2-(4-hydroxy-3-hydroxymethylphenyl) -2-hydroxyethyl)amino)-cyclohexane or alkyl-cyclohexane or -pyrazine derivatives; treating respiratory diseases disorders, asthma, bronchitis, nervous system injury |
| 07/14/2005 | WO2005064008A1 Method and compositions for identifying anti-hiv therapeutic compounds |
| 07/14/2005 | WO2005063705A1 Benzene compounds disubstituted with cyclic groups at the 1- and 2-positions |
| 07/14/2005 | US20050154200 Method for producing cyclic carbamate ester |
| 07/14/2005 | US20050153456 Analysis of mass spectral data in the quiet zones |
| 07/14/2005 | CA2550730A1 Method and compositions for identifying anti-hiv therapeutic compounds |
| 07/13/2005 | EP1553074A1 Fused benzene derivative and use |
| 07/13/2005 | CN1639201A Open-chain alkoxyamines and their corresponding nitroxides for controlled low temperature radical polymerization |
| 07/13/2005 | CN1639096A Process for producing trans-4-amino-1-cyclohexanecarboxylic acid derivative |
| 07/13/2005 | CN1636988A Process for preparing aryl ether |
| 07/13/2005 | CN1636983A Substituted heterocyclic compounds |
| 07/12/2005 | US6916808 2-thio-4h-3, 1-benzoxazin-4-one derivatives for use as enzyme inhibitors |
| 07/12/2005 | US6916667 Metal chelate containing compositions for use in chemiluminescent assays |
| 07/07/2005 | WO2005061491A2 Aralkyl and aralkylidene heterocyclic lactams with affinity for 5-ht1 receptors |
| 07/07/2005 | WO2005060663A2 Derivatives of gambogic acid and analogs as activators of caspases and inducers of apoptosis |
| 07/07/2005 | US20050148517 Carotenoid ether analogs or derivatives for controlling connexin 43 expression |
| 07/07/2005 | US20050147997 Blocking group(s) is released by reaction with trigger (phosphatase); optionally contains urea-containing group for attaching proteins, peptides or nucleic acids; rhodamine; kits |
| 07/07/2005 | CA2549308A1 Aralkyl and aralkylidene heterocyclic lactams with affinity for 5-ht1 receptors |
| 07/06/2005 | EP1550655A1 Bicyclic intermediates |
| 07/06/2005 | EP1549643A2 Method for preparing fused oxazinones from ortho-amino aromatic carboxylic acid and a carboxylic acid in the presence of a sulfonyl chloride and pyridine |
| 07/06/2005 | CN1636005A Benzothiazinone and benzoxazinone compounds |
| 07/06/2005 | CN1209352C Hydrazine derivatives |
| 07/05/2005 | US6914059 Benzoxazine and benzothiazine derivatives and the use thereof in medicaments |
| 07/05/2005 | US6913674 Process for fractionating water-containing crude amine mixtures from amine synthesis |
| 07/05/2005 | CA2220509C Fused polycyclic heterocycle derivatives |
| 06/30/2005 | WO2005058884A2 Cyclopropane compounds and pharmaceutical use thereof |
| 06/30/2005 | WO2005058847A1 Benzoxazine derivatives and uses thereof |
| 06/30/2005 | WO2005058846A1 Process for the porduction of dtpa-bis anhydride |
| 06/30/2005 | WO2005040357A3 Compounds and methods for fluorescent labeling |
| 06/30/2005 | US20050143475 Carotenoid analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injury |
| 06/30/2005 | CA2549660A1 Cyclopropane compounds and pharmaceutical use thereof |
| 06/30/2005 | CA2547764A1 Benzoxazine derivatives and uses thereof |
| 06/29/2005 | EP1546123A1 Benzyl morpholine derivatives |
| 06/29/2005 | EP1546116A1 Vanilloid receptor ligands and their use in treatments |
| 06/29/2005 | CN1208314C Factor VIIA inhibitor (thio) urea derivatives, their preparation and their use |
| 06/28/2005 | US6911477 Muscarinic receptor agonists |
| 06/23/2005 | WO2005056536A1 Antidiabetic agents which exhibit activity against ppar |
| 06/23/2005 | WO2005000406A3 Treatment of amyloid- and epileptogenesis-associated diseases |
| 06/23/2005 | US20050137438 3-bromo-5-chlorobenzonitrile, 4,4-dimethyl-2-oxo-1,4-dihydro-2H-benzo[d][1,3]oxazin-6-boronic acid, soda ash, ethanol and palladium or nickel catalyst on solid alkaline earth metal sulfate or carbonate support to form 3-chloro-5-(4,4-dimethyl-2-oxo-1,4-dihydro-2H-benzo[d][1,3]oxazin-6-yl)benzonitrile |
| 06/23/2005 | US20050137242 Betamimetics having a long-lasting activity, processes for preparing them, and their use as medicaments |
| 06/23/2005 | US20050137230 Factor Xa-inhibitors; preventing thromboembolic illnesses and tumors; 2-amino-N-(2'-methylsulfonylbiphenyl-4-yl)-3-phenylpropionamide |
| 06/22/2005 | EP1542692A1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain |
| 06/22/2005 | EP1082127B1 Succinamide inhibitors of interleukin-1beta converting enzyme |
| 06/22/2005 | CN1630632A Aromatic amino acid derivates and medicinal compositions |
| 06/22/2005 | CN1207289C Metalloproteinase inhibitors, pharmaceutical compositions containing the same and their pharmaceutical uses, and methods and intermediates useful for their preparation |
| 06/22/2005 | CN1207288C Retroviral protease inhibiting compounds |
| 06/21/2005 | US6908998 Method of producing ultraviolet radiation absorbent |
| 06/21/2005 | US6908917 Chromone derivatives as matrix metalloproteinase inhibitors |
| 06/21/2005 | US6908908 Biologically active 4H-benzo [1,4] oxazin-3-ones |
| 06/16/2005 | WO2005054871A2 Analysis of mass spectral data in the quiet zones |
| 06/16/2005 | WO2005053663A2 Norepinephrine reuptake inhibitors useful for treatment of cognitive failure |
| 06/16/2005 | US20050131216 Reagents for detecting efavirenz |
| 06/16/2005 | US20050131181 Isoprene-styrene copolymer, butadiene-styrene copolymer or butadiene-isoprene-styrene terpolymer randomly modified from 1-5%, e.g., of an p-(2-pyrrolidinoisopropyl-)styrene; tire tread; filler receptivity; low hysterises; rolling resistance; |
| 06/16/2005 | US20050131022 Such as 5-nitro-furan-2-carboxylic acid (2-piperidin-1-yl-phenyl)-amide; diabetes, angiogenesis, psoriasis, restenosis, schizophrenia, rheumatoid arthritis, cardiovascular disease, cancer |
| 06/16/2005 | US20050130962 Seratonin receptor antagonist; central nervous system disorders; halo phenyl substituents |
| 06/16/2005 | DE4304797B4 Verbessertes Verfahren zur Herstellung von 4,4-Diaryl-3,1-benzoxazinen Benzoxazines 4,4-diaryl-3,1-improved process for the preparation of |
| 06/16/2005 | CA2542941A1 Analysis of mass spectral data in the quiet zones and label selection therefor |
| 06/15/2005 | EP1542012A1 Antibodies for detecting efavirenz |
| 06/15/2005 | EP1539176A1 Thiazine and oxazine derivatives as mmp-13 inhibitors for treating arthritis |
| 06/15/2005 | EP1104412B1 Tace inhibitors |
| 06/15/2005 | EP1048658B1 Alicyclic acylated heterocyclic derivatives |
| 06/15/2005 | CN1627970A Safety shield system for prefilled syringe |
| 06/15/2005 | CN1206228C N-heterocyclic derivatives as NOS inhibitors |
| 06/15/2005 | CN1206213C N-arylsulfonyl amino acid omega amides |
| 06/14/2005 | CA2155952C Novel process for trans-6-[2-(substituted-pyrrol-1-yl)alkyl]pyran-2-one inhibitors of cholesterol synthesis |
| 06/10/2005 | CA2489266A1 Reagents for detecting efavirenz |
| 06/09/2005 | WO2005051934A1 Antithrombotic compounds with dual function |
| 06/09/2005 | WO2005051869A2 Carbon-carbon cross coupling catalyzed by transition metals on solid supports |
| 06/09/2005 | US20050124814 Addition polymers |
| 06/09/2005 | US20050124613 Benzoxazine derivatives and uses thereof |
| 06/09/2005 | US20050124612 E.g., 2-[2-carboxypropyl]-5-hydroxy-1,2-oxazin-3-one, more potent than desacetoxycephalosporin G; bactericides reacting irreversibly with the active site serine residue of the enzyme; enzyme inhibitors; mimetics; isocephalosporins; monocyclic beta-lactam antibiotics; antibiotic resistance |
| 06/09/2005 | US20050124050 Osteoclast differentiation inhibitors |
| 06/09/2005 | CA2546352A1 Carbon-carbon cross coupling catalyzed by transition metals on solid supports |